These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family. Rol N; Kurakula KB; Happé C; Bogaard HJ; Goumans MJ Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200294 [TBL] [Abstract][Full Text] [Related]
23. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension. Wang C; Xing Y; Zhang J; He M; Dong J; Chen S; Wu H; Huang HY; Chou CH; Bai L; He F; She J; Su A; Wang Y; Thistlethwaite PA; Huang HD; Yuan JX; Yuan ZY; Shyy JY Circ Res; 2022 Oct; 131(10):828-841. PubMed ID: 36252121 [TBL] [Abstract][Full Text] [Related]
24. Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension. Joshi SR; Liu J; Bloom T; Karaca Atabay E; Kuo TH; Lee M; Belcheva E; Spaits M; Grenha R; Maguire MC; Frost JL; Wang K; Briscoe SD; Alexander MJ; Herrin BR; Castonguay R; Pearsall RS; Andre P; Yu PB; Kumar R; Li G Sci Rep; 2022 May; 12(1):7803. PubMed ID: 35551212 [TBL] [Abstract][Full Text] [Related]
25. Sex-biased TGFβ signalling in pulmonary arterial hypertension. Wits M; Becher C; de Man F; Sanchez-Duffhues G; Goumans MJ Cardiovasc Res; 2023 Oct; 119(13):2262-2277. PubMed ID: 37595264 [TBL] [Abstract][Full Text] [Related]
26. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Orriols M; Gomez-Puerto MC; Ten Dijke P Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104 [TBL] [Abstract][Full Text] [Related]
33. Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling. Chen M; Shen H; Zhu L; Yang H; Ye P; Liu P; Gu Y; Chen S J Cell Physiol; 2019 Aug; 234(10):17482-17493. PubMed ID: 30786011 [TBL] [Abstract][Full Text] [Related]
34. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease. Upton PD; Morrell NW Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549 [TBL] [Abstract][Full Text] [Related]
35. Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances. Mercurio V; Cuomo A; Naranjo M; Hassoun PM Compr Physiol; 2021 Apr; 11(2):1805-1829. PubMed ID: 33792903 [TBL] [Abstract][Full Text] [Related]
36. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension. Gore B; Izikki M; Mercier O; Dewachter L; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Lebrin F; Eddahibi S PLoS One; 2014; 9(6):e100310. PubMed ID: 24956016 [TBL] [Abstract][Full Text] [Related]
37. Biological drug and drug delivery-mediated immunotherapy. Xiao Q; Li X; Li Y; Wu Z; Xu C; Chen Z; He W Acta Pharm Sin B; 2021 Apr; 11(4):941-960. PubMed ID: 33996408 [TBL] [Abstract][Full Text] [Related]